The global demand for Point of Care Infectious Disease Testing Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020 - 2026.
Point of Care Infectious Disease Testing is a testing mechanism used to test major pathogens in an environment setting very close to the patient and enable better management of infectious diseases. It is used to test several major diseases like HIV, HPV, TB, dengue, Ebola, Coronaviruses. This testing can help in the containment of rapid outbreaks of infectious diseases. They are commonly used in resource-limited settings where access to quality medical care in a timely manner is a challenge. Some examples of POCT are lateral flow immunoassays (LFIA) and enzyme immunoassay (ELISA). POCT will have a positive impact on society only if effective systems for reporting test results and follow up care are in place.
The high prevalence of infectious diseases and rapid outbreaks of viruses and epidemics globally are the main drivers for the growth of the POCT market. Availability of low-cost portable devices, ease of use in rural and remote areas, lack of healthcare infrastructure to meet the demands of the distressed will be major factors that will boost the growth of this market. Increased investments from governments for miniaturization and standardization of these testing methods will be a great market booster. Increase in the sales of ELISA kits during the COVID-19 pandemic led to the growth of the POCT market at an alarming rate. The major concerns hampering this market are lack of clinical sensitivity for specimens with low antigen levels and increased possibility of false-negative results.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of point of care infectious disease testing.
The entire point of care infectious disease testing market has been sub-categorized into disease and end-use. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
- HIV POC
- Clostridium Difficile POC
- HBV POC
- Pneumonia or Streptococcus Associated Infections
- Respiratory Syncytial Virus (RSV) POC
- HPV POC
- Influenza/Flu POC
- HCV POC
- MRSA POC
- TB and Drug-Resistant TB POC
- HSV (Herpes Simplex Virus) POC
- Other infectious disease POC
- Assisted Living Healthcare Facilities
This section covers regional segmentation which accentuates on current and future demand for point of care infectious disease testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Point of Care Infectious Disease Testing Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the point of care infectious disease testing market include Abbott, Bio-Rad Laboratories, Inc., Quest Diagnostics Inc., Thermo Fisher Scientific, Inc., Hoffmann-La Roche Ltd., Danaher, Siemens Healthineers, Sight Diagnostics Ltd., bioMérieux SA, Cardinal Health, Others. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.